Form 4 Tracker
INSMED Inc
INSM

49 insider filings · Latest: Aug 10, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 24, 2026Feb 25 9:04 PMMichael Alexander SmithChief Legal Officer
Sale
24,774$155.77$3.9M51,871(D)

View →

Feb 24, 2026Feb 24 9:33 PMMichael Smith
Proposed Sale
24,774$155.77$3.9M

View →

Feb 19, 2026Feb 23 9:34 PMWilliam LewisDirector, Chair and CEO
Sale
10,699$150.97$1.6M301,185(D)

View →

Feb 19, 2026Feb 19 9:54 PMWilliam Lewis
Proposed Sale
10,699$150.97$1.6M

View →

Feb 9, 2026Feb 11 9:42 PMWilliam LewisDirector, Chair and CEO
Sale
13,396$147.79$2.0M301,185(D)

View →

Feb 9, 2026Feb 9 10:32 PMWilliam Lewis
Proposed Sale
13,396$147.79$2.0M

View →

Feb 5, 2026Feb 6 9:18 PMMartina M.D. FlammerChief Medical Officer
Sale
869$152.44$132.5K83,243(D)

View →

Feb 5, 2026Feb 5 10:12 PMMartina Flammer
Proposed Sale
869$152.43$132.5K

View →

Feb 3, 2026Feb 4 9:20 PMRoger AdsettChief Operating Officer
Sale
791$156.17$123.5K106,810(D)

View →

Feb 3, 2026Feb 4 9:19 PMSara BonsteinChief Financial Officer
Sale
748$156.34$116.9K79,758(D)

View →

Feb 3, 2026Feb 4 9:17 PMWilliam LewisDirector, Chair and CEO
Sale
3,009$156.34$470.4K303,882(D)

View →

Feb 3, 2026Feb 4 9:15 PMMichael Alexander SmithChief Legal Officer
Sale
640$156.27$100.0K56,397(D)

View →

Feb 3, 2026Feb 4 9:15 PMMartina M.D. FlammerChief Medical Officer
Sale
795$155.77$123.8K84,112(D)

View →

Feb 2, 2026Feb 4 9:15 PMMartina M.D. FlammerChief Medical Officer
Sale
7,982$154.59$1.2M84,907(D)

View →

Feb 3, 2026Feb 3 10:04 PMRoger Adsett
Proposed Sale
791$156.16$123.5K

View →

Feb 3, 2026Feb 3 10:02 PMMichael Smith
Proposed Sale
640$156.27$100.0K

View →

Feb 3, 2026Feb 3 9:58 PMWilliam Lewis
Proposed Sale
3,009$156.33$470.4K

View →

Feb 3, 2026Feb 3 9:56 PMMartina Flammer
Proposed Sale
795$155.77$123.8K

View →

Feb 3, 2026Feb 3 9:55 PMSara Bonstein
Proposed Sale
748$156.33$116.9K

View →

Feb 2, 2026Feb 2 10:30 PMMartina Flammer
Proposed Sale
7,982$154.59$1.2M

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 20, 2026Jan 22 9:28 PMWilliam LewisDirector, Chair and CEO
Option Exercise
10,699$30.4653,280(D)

View →

← Previous

Page 2 of 2